Back to Search
ZI YANG JIANG, MD
MD
Pediatric Otolaryngology Physician
NPI: 1700016482IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Otolaryngology PhysicianPrimary
Otolaryngology — Pediatric Otolaryngology
Code: 207YP0228X
N8935(TX)
Otolaryngology Physician
Otolaryngology
Code: 207Y00000X
N8935(TX)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 2009
Research & Publications (20)
Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital.
PMID 19657721·Pharm World Sci·2009
4-observational
WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas.
PMID 19223017·Anaerobe·2009
8-other
Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
PMID 17618838·Clin Gastroenterol Hepatol·2007
8-other
Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries.
PMID 17893178·J Med Microbiol·2007
8-other
Rifaximin: in vitro and in vivo antibacterial activity--a review.
PMID 15855749·Chemotherapy·2005
6-review
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.
PMID 12898436·J Infect Dis·2003
8-other
Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers.
PMID 12409395·J Clin Microbiol·2002
8-other
Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay).
PMID 11865402·J Infect Dis·2002
8-other
Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997.
PMID 10669376·J Infect Dis·2000
8-other
In vitro activity and fecal concentration of rifaximin after oral administration.
PMID 10898704·Antimicrob Agents Chemother·2000
3-trial
Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide.
PMID 19669955·Med Oncol·2010
4-observational
The flavoheme reductase Ncb5or protects cells against endoplasmic reticulum stress-induced lipotoxicity.
PMID 19609006·J Lipid Res·2010
7-preclinical
The cryoprotective effect of low-density lipoproteins in extenders on bull spermatozoa following freezing-thawing.
PMID 19586728·Anim Reprod Sci·2010
7-preclinical
Circadian blood pressure and heart rate characteristics in haemorrhagic vs ischaemic stroke in Chinese people.
PMID 19571828·J Hum Hypertens·2010
4-observational
Biochemical mechanism of gallium on prevention of fatal cage-layer osteoporosis.
PMID 19639269·Biol Trace Elem Res·2010
7-preclinical
Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.
PMID 19598010·Med Oncol·2010
8-other
XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.
PMID 19669592·Mol Biol Rep·2010
1-meta
Henrylactones A-E and anti-HBV constituents from Illicium henryi.
PMID 19670158·Planta Med·2010
8-other
Swerilactones A and B, anti-HBV new lactones from a tradtional Chinese herb: Swertia mileensis as a treatment for viral hepatitis.
PMID 19673486·Org Lett·2009
8-other
[Progress on prevention and treatment of Chinese medicine to molecular mechanism of liver cancer].
PMID 19673399·Zhongguo Zhong Yao Za Zhi·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6431 FANNIN ST, MSB 5.036
HOUSTON, TX 77030 - Phone
- (713) 500-5410
Quick Facts
- NPI
- 1700016482
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile